Enzymotec Ltd. To Present at Two Upcoming Investor Conferences

MIGDAL HA'EMEQ, Israel, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq: ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that Dr. Ariel Katz, the Company’s Chief Executive Officer, is scheduled to present at the Jefferies Industrial Conference, being held August 9 – 11, 2016 in New York City and the Canaccord Genuity Annual Growth Conference, being held August 10 – 11, 2016 in Boston.

Details for the Company presentation are as follows:

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures, and markets innovative bio-active lipid based nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies intended to improve people’s health.  For more information, visit www.enzymotec.com.

Contact:

The Ruth Group
Tram Bui / Lee Roth
(646) 536-7035/7012
[email protected]
[email protected]

You May Also Be Interested In

• Curaleaf announces unsolicited takeover bid for Aurora Cannabis
• Gaotu Techedu to Report Second Quarter 2026 Financial Results on August 27, 2026
• DelphX closes two private placements raising C$125,000